Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /_ Disallow: /cgi-bin/ Disallow: /do/ Disallow: /*?*rf= #Disallow: / Disallow: /_cpanel Disallow: /cgi-bin/suppliers/ Disallow: /_mycart Disallow: /_myacct Sitemap: http://www.immuron.com.au/sitemap_index.xml.gz |
Title | Immuron |
Description | Clinical Insights & Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company (ASX: IMC) focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in |
Keywords | Immuron Australian biopharmaceutical immunotherapy |
WebSite | immuron.com.au |
Host IP | 52.62.248.101 |
Location | United States |
Site | Rank |
US$6,564,605
Last updated: 2022-06-15 22:56:14
immuron.com.au has Semrush global rank of 1,612,329. immuron.com.au has an estimated worth of US$ 6,564,605, based on its estimated Ads revenue. immuron.com.au receives approximately 757,455 unique visitors each day. Its web server is located in United States, with IP address 52.62.248.101. According to SiteAdvisor, immuron.com.au is safe to visit. |
Purchase/Sale Value | US$6,564,605 |
Daily Ads Revenue | US$6,060 |
Monthly Ads Revenue | US$181,790 |
Yearly Ads Revenue | US$2,181,469 |
Daily Unique Visitors | 50,497 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
immuron.com.au. | A | 3598 | IP: 52.62.248.101 |
immuron.com.au. | NS | 86400 | NS Record: ns-1434.awsdns-51.org. |
immuron.com.au. | NS | 86400 | NS Record: ns-1614.awsdns-09.co.uk. |
immuron.com.au. | NS | 86400 | NS Record: ns-389.awsdns-48.com. |
immuron.com.au. | NS | 86400 | NS Record: ns-854.awsdns-42.net. |
immuron.com.au. | MX | 3600 | MX Record: 10 mail.enetica.com.au. |
immuron.com.au. | TXT | 3600 | TXT Record: v=spf1 include:_spf.neto.com.au ~all |
+613 8892 4854 info@immuron.com : +613 8892 4854 info@immuron.com Cart - 0 Menu Shop Cart ( 0 ) Account About Us About Us Board of Directors Management Team Research Partners Technology Technology Platform Product Pipeline Intellectual Property Production Clinical Insights Commercial products In vitro studies into SARS-CoV-2 and IMM-124E Travelan US Army results Knowledge Centre Platform Science Product Science Investor Centre Company Media Analysts Reports Corporate Presentations Company Securities Exchange Announcements Capital Structure & Register Corporate Directory and Governance Corporate Contacts Contact Us Products Travelan® Protectyn® About Us About Us Board of Directors Management Team Research Partners Technology Technology Platform Product Pipeline Intellectual Property Production Clinical Insights Commercial products In vitro studies into SARS-CoV-2 and IMM-124E Travelan US Army results Knowledge Centre Platform Science Product Science Investor Centre Company Media |
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 13:29:12 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive location: https://www.immuron.com.au/ access-control-allow-methods: * access-control-allow-origin: * Strict-Transport-Security: max-age=31536000 HTTP/2 200 date: Thu, 21 Oct 2021 13:29:13 GMT content-type: text/html; charset=utf-8 x-frame-options: SAMEORIGIN vary: Accept-Encoding x-cache: 20425697 2365318 cache-control: max-age=0 cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cf_bm=sirUFhq5kY6nFvlCROIf7BnQvTYUG8WhZiDfCM2r4qY-1634822953-0-ARA48F8lk0M8l6vPYLnu/MXjTG13Wh802idxGmCycgziki1gDWkfP5lUlc+kCkqISwY47TcklVmCJDt/5eY5CQk=; path=/; expires=Thu, 21-Oct-21 13:59:13 GMT; domain=.www.immuron.com.au; HttpOnly; Secure; SameSite=None set-cookie: __cfruid=09148e8895946c364dfddccb4d011c1c18b8a76a-1634822953; path=/; domain=.www.immuron.com.au; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a1ad55f6a6f631a-ORD |
WHOIS LIMIT EXCEEDED |